Please use this identifier to cite or link to this item:
https://ahro.austin.org.au/austinjspui/handle/1/12287| Title: | ASPECCT: panitumumab versus cetuximab for colorectal cancer. | Austin Authors: | Hawkes, Eliza A ;Wong, Rachel | Affiliation: | Department of Medical Oncology, Eastern Health, Box Hill, Victoria, Australia Department of Oncology, Level 4, Olivia Newton-John Cancer and Wellness Centre, Austin Hospital, PO Box 5555, Heidelberg, VIC 3084, Australia |
Issue Date: | 1-Jul-2014 | Publication information: | The Lancet. Oncology; 15(8): e302-3 | Gov't Doc #: | 24988927 | URI: | https://ahro.austin.org.au/austinjspui/handle/1/12287 | DOI: | 10.1016/S1470-2045(14)70269-4 | Journal: | The Lancet. Oncology | URL: | https://pubmed.ncbi.nlm.nih.gov/24988927 | Type: | Journal Article | Subjects: | Antibodies, Monoclonal.therapeutic use Antibodies, Monoclonal, Humanized.therapeutic use Antineoplastic Agents.therapeutic use Colorectal Neoplasms.drug therapy Female Humans Male |
| Appears in Collections: | Journal articles |
Show full item record
Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.